Drug Allergy vs Side Effects

## Overview

Up to 80% of patients labeled as "drug allergic" do not have a true allergy upon formal testing. This mislabeling leads to avoidance of first-line therapies, use of broader-spectrum or more expensive alternatives, and measurably worse clinical outcomes. Accurate differentiation between allergy and side effects is one of the most impactful clinical skills.

## Defining Terms

**Side effects** (adverse drug reactions, Type A) are predictable, dose-dependent extensions of the drug's pharmacological action. Nausea from opioids, drowsiness from antihistamines, and diarrhea from antibiotics are side effects, not allergies.

**Drug allergy** (Type B) involves an immune-mediated response to a drug or its metabolite. It requires prior sensitization (or cross-reactive exposure), is not dose-dependent in the traditional sense, and involves specific immune mechanisms.

**Drug intolerance** describes an abnormally low threshold for a drug's known pharmacological effect (e.g., tinnitus from low-dose aspirin).

## Gell-Coombs Classification of Drug Allergy

**Type I (Immediate/IgE-mediated)**: Occurs within minutes to hours. Manifests as urticaria, angioedema, bronchospasm, or anaphylaxis. Penicillin allergy is the classic example. Skin prick testing and specific IgE assays can confirm.

**Type II (Cytotoxic/IgG-mediated)**: Drug-antibody complexes target cell surfaces. Causes hemolytic anemia (methyldopa), thrombocytopenia (heparin-induced), or neutropenia.

**Type III (Immune complex)**: Antigen-antibody complexes deposit in tissues. Causes serum sickness (beta-lactams, rituximab) with fever, rash, arthralgia 1-3 weeks after exposure.

**Type IV (Delayed/T-cell-mediated)**: Occurs 48-72 hours or longer after exposure. Includes contact dermatitis, DRESS syndrome, SJS/TEN, and maculopapular drug eruptions.

## Red Flags for True Allergy

Signs pointing to immune-mediated reaction rather than side effect include: onset after 5-7 days of first exposure (sensitization period), urticaria or angioedema, respiratory symptoms (wheezing, stridor), hypotension, eosinophilia, mucosal involvement, and recurrence upon rechallenge with any dose.

## The Penicillin Allergy Problem

Approximately 10% of patients report penicillin allergy, but over 90% of these patients tolerate penicillin upon formal testing. Many reported "allergies" were childhood side effects (GI upset, non-immune rashes), or the allergy has waned over time (IgE-mediated reactions resolve in 50% of patients within 5 years and 80% within 10 years). Penicillin skin testing followed by graded oral challenge has a negative predictive value exceeding 97%.

## Diagnostic Approach

A thorough history should capture the exact reaction, timing relative to drug exposure, concurrent medications, and whether the reaction resolved after drug withdrawal. Serum tryptase (elevated in anaphylaxis), specific IgE testing, and skin testing help confirm or exclude immune-mediated reactions.

## Key Takeaways

- Over 80% of reported drug "allergies" are not true immune-mediated reactions
- True allergies involve immune mechanisms (IgE, cytotoxic, immune complex, or T-cell)
- Side effects are dose-dependent and pharmacologically predictable
- Penicillin allergy should be formally evaluated — most patients can safely receive penicillins
- Accurate allergy documentation improves treatment outcomes and reduces healthcare costs